Angela Schulz

3.0k total citations · 1 hit paper
88 papers, 1.8k citations indexed

About

Angela Schulz is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Angela Schulz has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Physiology, 35 papers in Rheumatology and 29 papers in Molecular Biology. Recurrent topics in Angela Schulz's work include Lysosomal Storage Disorders Research (73 papers), Glycogen Storage Diseases and Myoclonus (34 papers) and Cellular transport and secretion (21 papers). Angela Schulz is often cited by papers focused on Lysosomal Storage Disorders Research (73 papers), Glycogen Storage Diseases and Myoclonus (34 papers) and Cellular transport and secretion (21 papers). Angela Schulz collaborates with scholars based in Germany, United States and United Kingdom. Angela Schulz's co-authors include Alfried Kohlschütter, Alessandro Simonati, Peter Slasor, David Jacoby, Temitayo Ajayi, Miriam Nickel, Ruth Williams, Nicola Specchio, Jonathan W. Mink and Paul Gissen and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Angela Schulz

78 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

2018 310 citations Angela Schulz, Nicola Specchio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Schulz Germany	20	1.3k	646	630	374	235	88	1.8k
Charles Marques Lourenço Brazil	23	667 0.5×	247 0.4×	883 1.4×	144 0.4×	96 0.4×	106	1.9k
Irène Maire France	21	950 0.7×	358 0.6×	351 0.6×	379 1.0×	52 0.2×	42	1.5k
Marianne Hoogeveen‐Westerveld Netherlands	27	1.2k 0.9×	178 0.3×	706 1.1×	522 1.4×	42 0.2×	57	1.8k
J. L. M. Keulemans Netherlands	20	834 0.7×	250 0.4×	587 0.9×	261 0.7×	44 0.2×	32	1.4k
Lucie Vérot France	10	671 0.5×	219 0.3×	337 0.5×	77 0.2×	121 0.5×	11	1.0k
Ekaterina Zakharova Russia	16	439 0.3×	164 0.3×	311 0.5×	119 0.3×	23 0.1×	128	962
Ian M. Williams United Kingdom	17	510 0.4×	174 0.3×	454 0.7×	50 0.1×	132 0.6×	25	1.1k
Denise Cassandrini Italy	23	252 0.2×	185 0.3×	735 1.2×	315 0.8×	22 0.1×	62	1.3k
Huizhi Zhao China	17	513 0.4×	223 0.3×	519 0.8×	133 0.4×	39 0.2×	35	1.3k
Anna-Elina Lehesjoki Finland	10	345 0.3×	172 0.3×	395 0.6×	115 0.3×	52 0.2×	10	768

Countries citing papers authored by Angela Schulz

Since Specialization

Citations

This map shows the geographic impact of Angela Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Schulz more than expected).

Fields of papers citing papers by Angela Schulz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Schulz. The network helps show where Angela Schulz may publish in the future.

Co-authorship network of co-authors of Angela Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Schulz. A scholar is included among the top collaborators of Angela Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Schulz. Angela Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cook, Anthony L., Erika F. Augustine, Aidan Bindoff, et al.. (2026). A timeline of symptom onset and disease progression in CLN3 disease. Orphanet Journal of Rare Diseases. 21(1). 38–38.

Schulz, Angela, et al.. (2025). Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa. Frontiers in Neurology. 16. 1516026–1516026. 1 indexed citations

Basavarajappa, Devaraj, Mehdi Mirzaei, Angela Schulz, et al.. (2025). Glial and immune dysregulation in glaucoma independent of retinal ganglion cell loss: a human post-mortem histopathology study. Acta Neuropathologica Communications. 13(1). 141–141. 3 indexed citations

Specchio, Nicola, Paul Gissen, Emily de los Reyes, et al.. (2024). Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data. PLoS ONE. 19(5). e0302382–e0302382. 2 indexed citations

Gissen, Paul, Asthik Biswas, Kshitij Mankad, et al.. (2024). Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History Cohort. American Journal of Neuroradiology. 45(11). 1791–1797. 2 indexed citations

Dulz, Simon, et al.. (2024). Peripapillary Retinal Nerve Fiber Layer (pRNFL) Thickness – A Novel Biomarker of Neurodegeneration in Late-Infantile CLN2 Disease. PubMed. Volume 16. 101–113.

Nickel, Miriam, Paul Gissen, Simona Cappelletti, et al.. (2023). Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?. Neuropediatrics. 54(6). 402–406. 3 indexed citations

Schulz, Angela, Nicola Specchio, Emily de los Reyes, et al.. (2023). Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study. The Lancet Neurology. 23(1). 60–70. 15 indexed citations

Schulz, Angela, Miriam Nickel, Susanne Lezius, et al.. (2022). Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker. Neuroradiology. 64(10). 2059–2067. 7 indexed citations

10.

Augustine, Erika F., Heather Adams, Emily de los Reyes, et al.. (2021). Management of CLN1 Disease: International Clinical Consensus. Pediatric Neurology. 120. 38–51. 17 indexed citations

11.

Gissen, Paul, Nicola Specchio, Andrew Olaye, et al.. (2021). Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2). Orphanet Journal of Rare Diseases. 16(1). 217–217. 10 indexed citations

12.

Kohlschütter, Alfried, Angela Schulz, Udo Bartsch, & Stephan Storch. (2019). Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses. CNS Drugs. 33(4). 315–325. 74 indexed citations

13.

Tiede, Stephan, Melanie Thelen, Reijo Käkelä, et al.. (2019). Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking. Journal of Biological Chemistry. 294(24). 9592–9604. 41 indexed citations

14.

Nickel, Miriam, et al.. (2018). FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients. Neuropediatrics. 49.

15.

Kohlschütter, Alfried, et al.. (2015). Ethical issues with artificial nutrition of children with degenerative brain diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(7). 1253–1256. 3 indexed citations

16.

Kohlschütter, Alfried, et al.. (2015). Reprint of "Ethical issues with artificial nutrition of children with degenerative brain diseases". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(10). 2312–2315.

17.

Schulz, Angela, Jonas Denecke, & Alfried Kohlschütter. (2015). Epilepsy in neuronal ceroid lipofuscinoses. 3(4). 199–206. 6 indexed citations

18.

Kohlschütter, Alfried, et al.. (2014). Phenotyping heterozygous carriers of juvenile neuronal ceroid lipofuscinosis with CLN3 mutations. Graefe s Archive for Clinical and Experimental Ophthalmology. 253(8). 1245–1250. 2 indexed citations

19.

Schulz, Angela, Alfried Kohlschütter, Jonathan W. Mink, Alessandro Simonati, & Ruth Williams. (2013). NCL diseases — clinical perspectives. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(11). 1801–1806. 178 indexed citations

20.

Schulz, Angela, Sumeer Dhar, Svetlana N. Rylova, et al.. (2004). Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Annals of Neurology. 56(3). 342–350. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact